Cash from Investing (Quarterly) Chart

View Cash from Investing (Quarterly) for COR.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Cash from Investing (Quarterly) Chart
Start Trial

Historical Cash from Investing (Quarterly) Data

View and export this data back to 1997. Start Trial.
Date Value
June 30, 2026 -240.15M
March 31, 2026 -4.875B
December 31, 2025 -299.32M
September 30, 2025 -321.94M
June 30, 2025 -234.69M
March 31, 2025 -4.078B
December 31, 2024 -343.04M
September 30, 2024 -241.88M
June 30, 2024 -143.92M
March 31, 2024 -166.49M
December 31, 2023 -65.80M
September 30, 2023 -183.44M
June 30, 2023 -819.13M
March 31, 2023 -88.74M
December 31, 2022 -1.511B
September 30, 2022 -174.73M
June 30, 2022 143.46M
March 31, 2022 -194.04M
December 31, 2021 -143.12M
September 30, 2021 -171.35M
June 30, 2021 -5.656B
March 31, 2021 -248.82M
December 31, 2020 -65.41M
September 30, 2020 -101.76M
June 30, 2020 -110.31M
Date Value
March 31, 2020 -105.46M
December 31, 2019 -62.34M
September 30, 2019 -78.80M
June 30, 2019 -85.81M
March 31, 2019 -83.61M
December 31, 2018 -127.62M
September 30, 2018 -85.24M
June 30, 2018 -90.45M
March 31, 2018 -793.10M
December 31, 2017 -142.32M
September 30, 2017 -91.48M
June 30, 2017 -137.09M
March 31, 2017 -112.62M
December 31, 2016 -156.86M
September 30, 2016 -148.12M
June 30, 2016 -146.51M
March 31, 2016 -102.07M
December 31, 2015 -2.772B
September 30, 2015 -186.53M
June 30, 2015 -55.19M
March 31, 2015 -2.612B
December 31, 2014 -77.16M
September 30, 2014 -64.95M
June 30, 2014 -191.07M
March 31, 2014 -59.93M

Cash From Investing Definition

Represents the net cash flow from the company's investing activities. Investing activities represent the movement in the company's long-term assets.

Read full definition.

Cash from Investing (Quarterly) Range, Past 5 Years

View Cash from Investing (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash from Investing (Quarterly) Benchmarks

View Cash from Investing (Quarterly) Benchmarks
Start Trial
Cardinal Health, Inc. -284.00M
McKesson Corp. 1.024B
CVS Health Corp. -1.884B
Henry Schein, Inc. -13.00M
Accendra Health, Inc. -31.24M